It's quite reassuring watching all these companies attempt to create a product that is like Scenesse, only to fail miserably. We've seen trial after trial fail to achieve efficacy and/or safety. Even the illegal MT2, which does provide quite a dark tan, has a whole range of nasty side effects as a result of breaking the blood brain barrier (and requires a daily injection as opposed to a long lasting implant). Scenesse is the perfect drug, virtually no side effects (95% retention rate is indicative of that), and very impressive efficacy (in relation to many indications, both clinical but also cosmetic). The TikTokers and Hollywood stars will be tossing aside their Ozempic injections for the shiny new Scenesse implant, it's already so obvious how this'll play out.
If all that we've seen with other companies' failed forays into Clinuvel's territory doesn't prove the strength of the moat they have I don't know what will. They're not building a house here, but a castle, and no company will come close to being able to achieve what they will achieve thanks to decades of work (the no rush strategy will pay off handsomely)
Just a waiting game imo
- Forums
- ASX - By Stock
- Disc Medicine - Best comparison stock to Clinuvel
It's quite reassuring watching all these companies attempt...
-
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.20 |
Change
0.110(0.78%) |
Mkt cap ! $713.8M |
Open | High | Low | Value | Volume |
$14.02 | $14.28 | $13.94 | $441.2K | 31.24K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 70 | $14.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.22 | 138 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 231 | 14.180 |
4 | 140 | 14.170 |
4 | 171 | 14.160 |
7 | 345 | 14.150 |
2 | 137 | 14.140 |
Price($) | Vol. | No. |
---|---|---|
14.210 | 32 | 3 |
14.220 | 42 | 2 |
14.230 | 133 | 4 |
14.240 | 201 | 4 |
14.250 | 35 | 1 |
Last trade - 14.21pm 07/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
CUV (ASX) Chart |